Serial direct sodium removal in patients with heart failure and diuretic resistance

被引:2
|
作者
Rao, Veena S. [1 ,11 ]
Ivey-Miranda, Juan B. [1 ,2 ]
Cox, Zachary L. [3 ,4 ]
Moreno-Villagomez, Julieta [1 ,5 ]
Ramos-Mastache, Daniela [5 ]
Neville, Daniel [1 ]
Balkcom, Natasha [1 ]
Asher, Jennifer L. [6 ]
Bellumkonda, Lavanya [1 ]
Bigvava, Tamar [7 ]
Shaburishvili, Tamaz [7 ]
Bartunek, Jozef [8 ]
Wilson, F. Perry [9 ,10 ]
Finkelstein, Fredrick [9 ]
Maulion, Christopher [1 ]
Turner, Jeffrey M. [9 ]
Testani, Jeffrey M. [1 ,11 ]
机构
[1] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA
[2] Inst Mexicano Seguro Social, Hosp Cardiol, Mexico City, Mexico
[3] Lipscomb Univ, Dept Pharm Practice, Coll Pharm, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA
[5] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City, Mexico
[6] Yale Univ, Sch Med, Dept Med, Div Comparat Med, New Haven, CT USA
[7] Tbilisi Heart & Vasc Clin, 18-20 Ljubljana St, Tbilisi 0159, Georgia
[8] Onze Lieve Vrouw Hosp, Cardiovasc Ctr, Aalst, Belgium
[9] Yale Univ, Sch Med, Dept Med, Div Nephrol, New Haven, CT USA
[10] Yale Univ, Sch Med, Clin & Translat Res Accelerator, New Haven, CT USA
[11] Yale Univ, 135 Coll St,Suite 230, New Haven, CT 06510 USA
关键词
Cardiorenal syndrome; Diuretic; Heart failure; Sodium; SALT INTAKE; PATHOPHYSIOLOGY; ULTRAFILTRATION; STRATEGIES; INSIGHTS; THERAPY; BALANCE; STORAGE; KIDNEY;
D O I
10.1002/ejhf.3196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Loop diuretics may exacerbate cardiorenal syndrome (CRS) in heart failure (HF). Direct sodium removal (DSR) using the peritoneal membrane, in conjunction with complete diuretic withdrawal, may improve CRS and diuretic resistance. Methods and results Patients with HF requiring high-dose loop diuretics were enrolled in two prospective, single-arm studies: RED DESERT (n = 8 euvolaemic patients), and SAHARA (n = 10 hypervolaemic patients). Loop diuretics were withdrawn, and serial DSR was utilized to achieve and maintain euvolaemia. At baseline, participants required a median 240 mg (interquartile range [IQR] 200-400) oral furosemide equivalents/day, which was withdrawn in all participants during DSR (median time of DSR 4 weeks [IQR 4-6]). Diuretic response (queried by formal 40 mg intravenous furosemide challenge and 6 h urine sodium quantification) increased substantially from baseline (81 +/- 37 mmol) to end of DSR (223 +/- 71 mmol, p < 0.001). Median time to re-initiate diuretics was 87 days, and the median re-initiation dose was 8% (IQR 6-10%) of baseline. At 1 year, diuretic dose remained substantially below baseline (30 [IQR 7.5-40] mg furosemide equivalents/day). Multiple dimensions of kidney function such as filtration, uraemic toxin excretion, kidney injury, and electrolyte handling improved (p < 0.05 for all). HF-related biomarkers including N-terminal pro-B-type natriuretic peptide, carbohydrate antigen-125, soluble ST2, interleukin-6, and growth differentiation factor-15 (p < 0.003 for all) also improved. Conclusions In patients with HF and diuretic resistance, serial DSR therapy with loop diuretic withdrawal was feasible and associated with substantial and persistent improvement in diuretic resistance and several cardiorenal parameters. If replicated in randomized controlled studies, DSR may represent a novel therapy for diuretic resistance and CRS. Clinical Trial Registration: RED DESERT (NCT04116034), SAHARA (NCT04882358). [GRAPHICS] .
引用
收藏
页码:1215 / 1230
页数:16
相关论文
共 50 条
  • [1] SERIAL EVALUATION OF DIURETIC RESISTANCE IN PATIENTS WITH STAGE D HEART FAILURE UNDERGOING LVAD IMPLANTATION
    Beargie, Sarah M.
    Safley, Lindsey
    Tunney, Robert
    Cox, Zachary
    Zalawadiya, Sandip
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 657 - 657
  • [2] Diuretic treatment and diuretic resistance in heart failure
    Krämer, BK
    Schweda, F
    Riegger, GAJ
    AMERICAN JOURNAL OF MEDICINE, 1999, 106 (01): : 90 - 96
  • [3] Diuretic resistance in heart failure
    Iyengar S.
    Abraham W.T.
    Current Heart Failure Reports, 2006, 3 (1) : 41 - 45
  • [4] Diuretic Resistance in Heart Failure
    Gupta R.
    Testani J.
    Collins S.
    Current Heart Failure Reports, 2019, 16 (2) : 57 - 66
  • [5] Diuretic resistance in heart failure
    Trullas, Joan Carles
    Casado, Jesus
    MEDICINA CLINICA, 2024, 162 (01): : 19 - 21
  • [6] Diuretic Resistance in Heart Failure
    Rahman, Rubayat
    Paz, Pablo
    Elmassry, Mohamed
    Mantilla, Barbara
    Dobbe, Logan
    Shurmur, Scott
    Nugent, Kenneth
    CARDIOLOGY IN REVIEW, 2021, 29 (02) : 73 - 81
  • [7] Prediction of dialysis in heart failure patients with diuretic resistance
    Ge, C. Cheng
    Zhang, Y.
    Zhu, M.
    Zhang, S.
    Liu, Y. M.
    Chen, C.
    Zhang, Z. B.
    Dong, W.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 332 - 332
  • [8] Treatment strategies for diuretic resistance in patients with heart failure
    Horiuchi, Yu
    Wettersten, Nicholas
    JOURNAL OF CARDIOLOGY, 2025, 85 (01) : 1 - 7
  • [9] Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance
    Liu, Chao
    Liu, Gang
    Zhou, Caixia
    Ji, Zhenguo
    Zhen, Yuzhi
    Liu, Kunshen
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 (11) : 865 - 868
  • [10] NO DIFFERENCE IN SODIUM REMOVAL WITH ULTRAFILTRATION THERAPY VERSUS CONVENTIONAL DIURETIC THERAPY IN PATIENTS WITH ACUTE HEART FAILURE
    Koratala, A.
    Qadri, S. I.
    Kazory, A.
    CARDIOLOGY, 2016, 134 : 420 - 420